• Synthego Offers Free CRISPR Design Tool

    Bio-IT World News Brief | Synthego today announced new online CRISPR tools that make accessible over 100,000 genomes for free, fast, and easy world-class target design. Consisting of a guide designer and a design validator, Synthego’s software addresses gaps in the CRISPR design process, and allows both sophisticated and novice researchers to reduce the time it takes to create optimal designs from hours to minutes.

    May 16, 2017

  • Geneticists Enlist Engineered Virus And CRISPR To Battle Citrus Disease

    Nature News & Comment | Desperate farmers hope scientists can beat pathogen that is wrecking the US orange harvest.

    May 16, 2017

  • Scientists Raise Concern By Wanting To Create Synthetic Human Genomes

    NPR.org | In New York, hundreds of scientists discussed a highly ambitious and controversial project. They want to create synthetic genetic codes for all kinds of creatures - including the human genetic code.

    May 15, 2017

  • Nvidia CEO Software Is Eating the World but AI Is Going to Eat Software

    MIT Technology Review | Jensen Huang predicts that health care and autos are going to be transformed by artificial intelligence.

    May 12, 2017

  • Deep Genomics Shifts Focus to Genetic Medicines

    Bio-IT World | Earlier this month Deep Genomics announced a shift in company focus. Genetic testing was the Deep Genomics business plan in August of 2015; today the company is working to develop genetic medicines.

    May 12, 2017

  • Hacking Bio-IT: Bio-IT World Launches First Hackathon

    Bio-IT World | At the end of May, the Bio-IT World Conference & Expo will host its first Bio-IT Hackathon, this year focusing on FAIR data, data that are findable, accessible, interoperable, and reusable.

    May 10, 2017

  • Edico Announces $22M Round

    Bio-IT World News Brief | Edico Genome announced today it has raised $22 million in a Series B financing to expand market adoption and product development of its DRAGEN platform. New investor Dell Technologies Capital, the venture arm of Dell Technologies, led the round and all existing investors participated, including Qualcomm Ventures, Axon Ventures and life sciences industry executive Greg Lucier.

    May 9, 2017